CEACAM5 and colorectal carcinoma: In CRC fluorescence-guided surgery, the carcinoembryonic antigen (CEA)-targeted probe SGM-101 has advanced to multicenter clinical trials, showing that a 10 mg dose administered 4 days before surgery significantly improved sensitivity and lesion detection.21